National Institutes of Health: Hydroxychloroquine does not benefit adults hospitalized with COVID-19

National Institutes of Health: Hydroxychloroquine does not benefit adults hospitalized with COVID-19. “A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients.”

Leave a Reply